Analyst consensus rating
Hims & Hers Health Analyst Rating: Hold
Direct answer
Hims & Hers Health's consensus rating is Hold.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $31.15.
Forecast evidence checked November 3, 2026.
Get free Hims & Hers Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $25.24
- Average price target
- $31.15
- High price target
- $42.00
- Low price target
- $23.00
- Low target gap
- -8.9%
- Target upside
- +23.4%
- High target gap
- +66.4%
- Target range width
- 75.3%
- Consensus rating
- Hold
- Analysts
- 13
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Hims & Hers Health?
Hims & Hers Health has a verified Hold consensus. The same dataset has an average price target of $31.15.
How far are Hims & Hers Health's low and high targets from the recorded price?
The low target implies -8.9%, while the high target implies +66.4%.
How many analysts are included in Hims & Hers Health's consensus?
The verified consensus includes 13 analysts.
How is Hims & Hers Health's target upside or downside calculated?
The average target of $31.15 is divided by the recorded price of $25.24, then one is subtracted to produce +23.4%. This does not guarantee a future return.
When was Hims & Hers Health's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.